Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831116 · ClinicalTrials.gov registry record
An Observational Study of Cholesterol in Coronary Arteries
A clinical trial of Coronary Artery Disease and Myocardial Infarction, sponsored by Infraredx.
- Completed
- Registry status
- 2,067
- Enrollment target
- 20
- Study locations
NCT00831116: Completed study of Coronary Artery Disease and Myocardial Infarction, sponsored by Infraredx.
NCT00831116 is a study of Coronary Artery Disease and Myocardial Infarction that has completed, run by Infraredx. The registered enrollment target is 2,067 participants, above the 1,278-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (62% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00831116, a study of Coronary Artery Disease and Myocardial Infarction, has completed, sponsored by Infraredx.
- COMPLETED
- Registry status
- 2,067 participants
- Enrollment target
- 20
- Study locations
Study Summary
In April 2008, a coronary catheter based imaging system, LipiScan, was cleared by the FDA for use in detecting lipid core containing containing plaques of interest (LCP). These plaques are rich in cholesterol. The way that cholesterol and other lipids deposit with the coronary artery is unique to each patient. This study is an organized attempt to observe the LCP and the variety of ways that it presents in patients as detected by this recently approved device. This information will be used for physician training and to observe the behavior of the LCP in response to no therapy and currently approved therapies. The purpose of this project is further medical knowledge of the LCP and its treatment.
Conditions Studied
Interventions
- DEVICE Intravascular Near Infrared Spectroscopy
Study Locations (20)
California
- University of California, Los Angeles Medical Center - Los Angeles
- University of California Irvine Medical Center - Orange
- San Francisco Veterans Affairs Medical Center - San Francisco
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
- Lahey Clinic - Burlington
Arizona
- Mercy Gilbert Medical Center - Gilbert
- Scottsdale Healthcare - Scottsdale
Florida
- University of Florida, Gainesville - Gainesville
- Pepin Heart Hospital - Tampa
Michigan
- Crittenton Shelton Heart Center: - Rochester Hills
- William Beaumont Hospital - Royal Oak
New York
- Mount Sinai School of Medicine - New York
- Columbia Universtiy Medical Center - New York
Georgia
- Piedmont Hospital - Atlanta
Maryland
- Washington Adventist Hospital - Takoma Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,067 participants |
| Start Date | 2009-02 |
| Est. Completion | 2017-04 |
What the finished NCT00831116 record still lists
NCT00831116 is an observational study that tracks outcomes without assigning an intervention. Its 2,067 participants enrollment target places it among the larger protocols in the corpus, above the 1,278-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (62% higher).
The record links to 4 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Intravascular Near Infrared Spectroscopy is the first listed.
NCT00831116 names 20 study sites across 12 states, led by California, Massachusetts, Arizona.
Frequently Asked Questions
What is clinical trial NCT00831116 about?
NCT00831116 is a clinical study titled "An Observational Study of Cholesterol in Coronary Arteries". In April 2008, a coronary catheter based imaging system, LipiScan, was cleared by the FDA for use in detecting lipid core containing containing plaques of interest (LCP). These plaques are rich in cholesterol. The way that cholesterol and other lipids deposit with the coronary artery is unique to ea...
What is the current status of trial NCT00831116?
This trial is currently completed. The enrollment target is 2,067 participants. The study started on 2009-02. Estimated completion is 2017-04.
What conditions does trial NCT00831116 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Infarction, Myocardial Ischemia, Angina.
What interventions are being tested in trial NCT00831116?
The interventions under investigation include: Intravascular Near Infrared Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00831116?
This trial is sponsored by Infraredx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00831116 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00831116's enrollment target sits among peer trials
2,067 28th of 219 higher than 192 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06666192 · 2,067 participants · NA
The Ohio State University (OSU) SCREEN Community Program
- NCT00588068 · 2,070 participants
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
- NCT07168993 · 2,063 participants · NA
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia